Loading...
XASXMX1
Market cap29mUSD
Jan 10, Last price  
0.08AUD
1D
1.23%
1Q
17.14%
Jan 2017
-82.95%
IPO
-85.49%
Name

Micro-X Ltd

Chart & Performance

D1W1MN
XASX:MX1 chart
P/E
—
P/S
3.14
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
28.39%
Rev. gr., 5y
51.13%
Revenues
15m
+1.45%
0072,000892,000659,0001,607,0001,931,0004,251,0003,771,0008,970,00015,005,00015,222,000
Net income
-10m
L-9.20%
76,796-385,533-10,163,000-10,741,000-12,920,000-16,594,999-9,834,000-10,067,000-14,731,000-17,089,000-10,754,000-9,765,000
CFO
-6m
L-41.46%
42,849-242,638-5,817,000-12,523,000-10,518,000-7,838,000-7,154,000-9,456,000-9,857,000-18,108,000-10,993,000-6,435,000
Earnings
Feb 26, 2025

Profile

Micro-X Limited designs, develops, and manufactures lightweight carbon nano tube-based X-ray products for the healthcare and security imaging markets in Australia. The company offers rover veterinary, a mobile X-ray machine to diagnose and treat animals for general veterinarian practices; Carestream DRX Revolution Nano, a mobile X-ray imaging machine used for high intensity workflow diagnostic medical imaging in hospitals; and IED X-ray cameras. It also provides miniature baggage scanners to detect hidden threats concealed within passenger carry-on luggage; airport screening reimagined, a passenger self-screening airport checkpoint; and brain CT scanners for use in road and air ambulances. The company was incorporated in 2011 and is based in Tonsley, Australia.
URL
https://micro-x.com/
IPO date
Dec 22, 2015
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
15,222
1.45%
15,005
67.28%
8,970
137.87%
Cost of revenue
27,807
24,591
23,350
Unusual Expense (Income)
NOPBT
(12,585)
(9,586)
(14,380)
NOPBT Margin
Operating Taxes
(6,647)
(3,655)
Tax Rate
NOPAT
(12,585)
(2,939)
(10,725)
Net income
(9,765)
-9.20%
(10,754)
-37.07%
(17,089)
16.01%
Dividends
Dividend yield
Proceeds from repurchase of equity
5,525
7,245
BB yield
-12.63%
-12.18%
Debt
Debt current
692
(129)
633
Long-term debt
7,288
7,954
4,746
Deferred revenue
Other long-term liabilities
703
875
5,509
Net debt
4,752
2,602
(4,924)
Cash flow
Cash from operating activities
(6,435)
(10,993)
(18,108)
CAPEX
(369)
(779)
(1,112)
Cash from investing activities
(369)
(779)
(1,112)
Cash from financing activities
4,809
6,692
(612)
FCF
(10,840)
(5,306)
(15,000)
Balance
Cash
3,228
5,223
10,303
Long term investments
Excess cash
2,467
4,473
9,854
Stockholders' equity
14,261
17,128
19,224
Invested Capital
16,487
18,233
15,576
ROIC
ROCE
EV
Common stock shares outstanding
527,175
495,807
460,277
Price
0.08
-30.83%
0.12
-14.29%
0.14
-56.25%
Market cap
43,756
-26.46%
59,497
-7.67%
64,439
-49.42%
EV
48,508
62,099
59,515
EBITDA
(11,034)
(7,997)
(12,948)
EV/EBITDA
Interest
248
269
296
Interest/NOPBT